Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
20–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Body Mass Index ≥25 kg/m²
Viceral Fat Area ≥ 100 cm²
Diet therapy for more than 8 weeks before start of the placebo observation period
Stable weight (variation \< ±3kg within 8 weeks before start of observation period)
At least 2 criteria of the following 3 comorbidities: Impaired Glucose Tolerance or Type 2 diabetes, Dyslipidemia (hypertriglyceridemia and/or low HDL-choresterol), Hypertension
Clareo Health | Japanese Dose-Response Study of Rimonabant in Obese Patients
